RIVASTIGMIN Zentiva Patch 9.5 mg/24h 30 pce
7680629170082
CH-62917
N06DA03
01.99.0.
Reimbursement limitations:
THERAPIEBEG
En début de thérapie, application par ex. d'un test minimental.
Première évaluation intermédiaire après trois …
1 / 3
google
Details
- Product number
- 6291702
- CPT
- -
- Packaging group
- 30
- Unit
- Pflaster
- Composition
- rivastigminum 13.8 mg, excipiens ad praeparationem pro 9.2 cm² cum liberatione 9.5 mg/24h.
Articles (1)
Rivastigmin Zentiva Patch 9.5 mg/24 h, transdermales Pflaster
Transdermales Pflaster
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
13.8 MG | Substance | Wirkstoff (Principe actif) |
|
2-ethylhexylis acrylatis et vinylis acetatis polymerisatum
|
- | Substance | HNIDK |
|
polyisobutylenum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
paraffinum perliquidum
|
- | Substance | HNIDK |
|
polyethylenum
|
- | Substance | HNIDK |
|
polyesterum
|
- | Substance | HNIDK |
|
aluminium metallicum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 59.40
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2018
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 62917
- Drug name
- Rivastigmin Zentiva Patch, transdermales Pflaster
- Galenic form
- TRAP
- ATC Code
- N06DA03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/03/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RIVASTIGMIN Zentiva Patch 9.5 mg/24h 30 pce
- Description (DE)
- RIVASTIGMIN Zentiva Patch 9.5 mg/24h 30 Stk
- Market launch
- 27/03/2014
- Narcotic (BTM)
- No